An alternative non-invasive treatment for Peyronie's disease

International Braz J Urol

Volumn 30, Issue 3, 2004, Pages 199-204

  Claro, Joaquim A ^a,b   Passerotti, Carlo C ^a   Figueiredo Neto, Antonio C ^a   Nardozza Jr , Archimedes ^a   Ortiz, Valdemar ^a   Srougi, Miguel ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Extracorporeal shockwave lithotripsy; Penis; Peyronie's disease; Treatment; Vitamin E.

Indexed keywords

ALPHA TOCOPHEROL; BENZOIC ACID; COLCHICINE DERIVATIVE; SILDENAFIL; STEROID; TADALAFIL; TAMOXIFEN; VARDENAFIL; VERAPAMIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; ERECTILE DYSFUNCTION; EXTRACORPOREAL LITHOTRIPSY; HEMATOMA; HUMAN; MALE; MEDICAL ASSESSMENT; MEDICAL PHOTOGRAPHY; PATIENT SATISFACTION; PENIS ERECTION; PEYRONIE DISEASE; PROSPECTIVE STUDY; SIDE EFFECT; SKIN BRUISING; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; ULTRASOUND SCANNER; URETHRAL BLEEDING;

EID: 4043082033     PISSN: 16775538     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1677-55382004000300004     Document Type: Article

References (15)

1. Gelbard MK, Dorey F, James R: The natural history of Peyronie's disease. J Urol. 1990; 44: 1376-9.
2. Devine CJ Jr, Somers KD, Jordan GH, Schiossberg SM: Proposal: trauma as the cause of the Peyronie's lesion. J Urol. 1997; 157: 285-90.
3. Jarrow JP, Lowe FC: Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction. J Urol. 1997; 158: 1388-90.
4. Wahl SM: Inflammation and growth factors. J Urol. 1997; 157: 303-5.
5. El-Sakka AI, Hassan MU, Nunes L, Bhatnagar RS, Yen TS, Lue TF: Histological and ultrastructural alterations in an animal model of Peyronie's disease. Br J Urol. 1998; 81: 445-452.
6. Smith BH: Subclinical Peyronie's disease. Am J Clin Pathol. 1969; 52: 385-90.
7. Gelbard MK, Dorsey F, James K: The natural history of Peyronie's disease. J Urol. 1990; 144: 1376-9.
8. Lindsay MB, Schain DM, Grambsch P, Benson RC, Beard CM, Kurland LT: The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. J Urol. 1991; 146: 1007-9.
9. Carson CC, Jordan GH, Gelbard MK: Peyronie's disease: new concepts in etiology, diagnosis and treatment. Contemp Urol. 1999; 11: 44-64.
10. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U: The prevalence of Peyronie's disease: results of a large survey. BJU Int. 2001, 88: 727-30.
11. Gholanni SS, Gonzalez-Cadavid NF, Lin CS, Rajfer J, Lue TF: Peyronie's disease: a review. J Urol. 2003; 169: 1234-41.
12. Husain J, Lynn MN, Jones DK, Collins GN, O'Reilly PH: Extra corporeal shockwave therapy in the management of Peyronie's disease: initial experience. BJU Int. 2000; 86: 466-8.
13. Hamm R, McLarty E, Ashdown J, Natale S, Dicthison A: Peyronie's disease: the Plymonth experience of extracorporeal shockwave treatment. BJU Int. 2001, 87: 849-52, 2001.
14. Somers KD, Dawson DM: Fibrin deposition in Peyronie's disease plaque. J Urol. 1997; 157: 311-5.
15. Lingeman JE, McAteer JA, Kempon SA, Evan AP: Bioeffects of extracorporeal shock wave lithotripsy: strategy for research and treatment. Urol Clin North Amer.1988; 15: 507-14.